The analysis of blood samples and enzalutamide-resistant PCa cell lines in patients with CRPC who developed resistance to enzalutamide revealed increased numbers of PD-L1/L2-positive circulating dendritic cells in the bloodstream of enzalutamide-resistant patients with CRPC. Here, CD274 is linked to posterior cortical atrophy.